251 related articles for article (PubMed ID: 19410469)
1. Intracellular uptake of a new boronated porphyrin EC032.
Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
[TBL] [Abstract][Full Text] [Related]
2. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
3. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
4. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
5. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
6. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
Clin Cancer Res; 2000 Feb; 6(2):725-30. PubMed ID: 10690559
[TBL] [Abstract][Full Text] [Related]
7. New approach to incorporation of boron in tumor-seeking molecules.
Sivaev IB; Semioshkin AA; Bregadze VI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
[TBL] [Abstract][Full Text] [Related]
8. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
[TBL] [Abstract][Full Text] [Related]
10. Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system.
Morris GM; Coderre JA; Hopewell JW; Micca PL; Nawrocky M; Miura M
Int J Radiat Biol; 2003 Mar; 79(3):149-58. PubMed ID: 12745879
[TBL] [Abstract][Full Text] [Related]
11. In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Migneco LM; Campanella R; Maraviglia B; Pastore FS
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924
[TBL] [Abstract][Full Text] [Related]
12. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides.
Fairchild RG; Kahl SB; Laster BH; Kalef-Ezra J; Popenoe EA
Cancer Res; 1990 Aug; 50(16):4860-5. PubMed ID: 2379150
[TBL] [Abstract][Full Text] [Related]
13. Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT.
Hiramatsu R; Kawabata S; Miyatake S; Kuroiwa T; Easson MW; Vicente MG
Lasers Surg Med; 2011 Jan; 43(1):52-8. PubMed ID: 21254143
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
[TBL] [Abstract][Full Text] [Related]
15. Conjugates of boron clusters with derivatives of natural chlorin and bacteriochlorin.
Bregadze VI; Sivaev IB; Lobanova IA; Titeev RA; Brittal DI; Grin MA; Mironov AF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S101-4. PubMed ID: 19447631
[TBL] [Abstract][Full Text] [Related]
16. Development of boron nanocapsules for neutron capture therapy.
Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
[TBL] [Abstract][Full Text] [Related]
17. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
20. Positive cooperativity in the cellular uptake of a boronated porphyrin.
Novick S; Laster B; Quastel MR
Int J Biochem Cell Biol; 2006; 38(8):1374-81. PubMed ID: 16616577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
